Viz.ai Announces Successful Completion of SOC 2 Type II + HIPAA Audits for...
Validates Viz.ai as a trusted and secure platform for health systems for the fourth consecutive year SAN FRANCISCO – February...
Feb 26, 2024
All Resources
Explore our latest resources
Navigating the Future of Healthcare: Viz.ai’s Insights from J.P. Morgan Healthcare Conference 2024
The 2024 J.P. Morgan Healthcare Conference provided a robust platform for leaders, innovators, and disruptors in the healthcare industry to...
Feb 09, 2024
Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of...
New AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisions SAN FRANCISCO...
Feb 08, 2024
Viz.ai Announces Six Clinical Studies that Further Validate Impact of Viz™ Neuro Suite...
Real-world evidence presented at the 2024 International Stroke Conference shows positive impact on clinical workflow and patient benefits of AI-powered...
Feb 07, 2024
Viz.ai Adoption Surpasses 1,500 Hospitals Nationwide
Continued record growth with 45,000 healthcare providers on Viz.ai One and collaborations with 7 top life science companies reaffirm Viz.ai's...
Jan 08, 2024
Jan 08, 2024
Mitigating pharma’s losses from missed diagnoses and lost-to-follow-up: Does AI have a role?
Read now on Fierce Pharma. Every year, too many people with health problems fall through the cracks of a complex...